The group approach is unique in integrating body and mind, using the language of the body as a form of counselling to help participants who have presented to the National Health Service with physical conditions which appear to have no medical explanation.
It forms part of a research project run by the Health and Human Sciences Research Institute, in conjunction with the Primary Care Trust (PCT).
According to Professor Helen Payne, principal investigator, who is currently recruiting for the next phase of this research, most of the participants in the groups had not had to see their GP since referral to the group and a quarter of them had a reduction in their medication or came off it completely.
“We have seen that since coming to the groups, participants have experienced significant changes in lifestyle, reduction in symptom distress, an increase in self-understanding and general increases in wellbeing,” said Professor Payne.
She also reported that symptoms presented by participants such as Irritable Bowel Syndrome, bladder problems, ME, panic attacks, joint pain or headaches, disappeared entirely or reduced once they joined one of the groups, enabling many of them to work or study again.She commented: "Through recognising that if symptoms arise in the body then we need to work with and through the body, we have enabled many of the participants to resume work or study and to do things that they couldn’t do before. Our approach is very holistic using the inter-relationship of body with mind and we are gathering more and more evidence that it works."
Professor Payne and her team conduct three-monthly follow-ups to measure whether recovery from symptoms has been sustained.
For further information about the next course, please contact Professor Helen Payne, Tel: 01438 833440, email: firstname.lastname@example.org.
Helene Murphy | alfa
Statistical method developed at TU Dresden allows the detection of higher order dependencies
07.02.2020 | Technische Universität Dresden
Novel study underscores microbial individuality
13.12.2019 | Bigelow Laboratory for Ocean Sciences
Together with their colleagues from the University of Würzburg, physicists from the group of Professor Alexander Szameit at the University of Rostock have devised a “funnel” for photons. Their discovery was recently published in the renowned journal Science and holds great promise for novel ultra-sensitive detectors as well as innovative applications in telecommunications and information processing.
The quantum-optical properties of light and its interaction with matter has fascinated the Rostock professor Alexander Szameit since College.
Researchers at the University of Zurich show that different stem cell populations are innervated in distinct ways. Innervation may therefore be crucial for proper tissue regeneration. They also demonstrate that cancer stem cells likewise establish contacts with nerves. Targeting tumour innervation could thus lead to new cancer therapies.
Stem cells can generate a variety of specific tissues and are increasingly used for clinical applications such as the replacement of bone or cartilage....
An international research team led by Kiel University develops an extremely porous material made of "white graphene" for new laser light applications
With a porosity of 99.99 %, it consists practically only of air, making it one of the lightest materials in the world: Aerobornitride is the name of the...
Researchers at Graz University of Technology have developed a framework by which wireless devices with different radio technologies will be able to communicate directly with each other.
Whether networked vehicles that warn of traffic jams in real time, household appliances that can be operated remotely, "wearables" that monitor physical...
Terahertz waves are becoming ever more important in science and technology. They enable us to unravel the properties of future materials, test the quality of...
26.03.2020 | Event News
23.03.2020 | Event News
03.03.2020 | Event News
27.03.2020 | Power and Electrical Engineering
27.03.2020 | Life Sciences
27.03.2020 | Life Sciences